Margaret Tooth Sells 491 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 491 shares of the business’s stock in a transaction on Monday, May 25th. The stock was sold at an average price of $21.86, for a total transaction of $10,733.26. Following the completion of the transaction, the chief executive officer directly owned 176,379 shares in the company, valued at $3,855,644.94. This trade represents a 0.28% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Trupanion Price Performance

Shares of TRUP stock traded down $0.17 during mid-day trading on Wednesday, hitting $21.69. The company had a trading volume of 371,901 shares, compared to its average volume of 428,641. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $57.88. The stock’s 50 day moving average price is $25.08 and its 200-day moving average price is $30.52. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The company has a market capitalization of $946.12 million, a P/E ratio of 36.76 and a beta of 1.49.

Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping the consensus estimate of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The firm had revenue of $384.05 million for the quarter, compared to the consensus estimate of $379.77 million. During the same quarter in the previous year, the firm earned ($0.03) earnings per share. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. Equities research analysts forecast that Trupanion, Inc. will post 0.53 earnings per share for the current year.

Institutional Investors Weigh In On Trupanion

A number of hedge funds have recently bought and sold shares of the business. Millennium Management LLC increased its position in Trupanion by 185.8% during the third quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after acquiring an additional 402,421 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Trupanion by 116.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock valued at $17,826,000 after acquiring an additional 256,559 shares during the last quarter. Two Sigma Investments LP increased its position in Trupanion by 3,201.0% during the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock valued at $9,713,000 after acquiring an additional 217,634 shares during the last quarter. Polar Capital Holdings Plc increased its position in Trupanion by 13.5% during the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock valued at $55,121,000 after acquiring an additional 175,000 shares during the last quarter. Finally, Marshall Wace LLP increased its position in Trupanion by 15.5% during the third quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock valued at $52,462,000 after acquiring an additional 163,101 shares during the last quarter.

Analysts Set New Price Targets

Several research firms have recently commented on TRUP. Stifel Nicolaus lowered their target price on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, March 31st. Piper Sandler decreased their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Bank of America decreased their price target on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research note on Tuesday, April 14th. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Finally, Cantor Fitzgerald decreased their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Trupanion presently has an average rating of “Hold” and a consensus target price of $42.25.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.